Exane Derivatives’s uniQure QURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$149 Hold
8
﹤0.01% 698
2022
Q1
$145 Hold
8
﹤0.01% 978
2021
Q4
$166 Sell
8
-4,721
-100% -$135K ﹤0.01% 848
2021
Q3
$151K Sell
4,729
-46
-1% -$1.4K 0.04% 461
2021
Q2
$133K Buy
4,775
+825
+21% +$27.6K 0.03% 510
2021
Q1
$133K Buy
3,950
+1,593
+68% +$57.1K 0.04% 363
2020
Q4
$85.2K Buy
+2,357
New +$99.4K 0.03% 415
2019
Q1
Sell
-1,435
Closed -$41.3K 703
2018
Q4
$41.3K Buy
+1,435
New +$39.9K 0.01% 372

Other funds holding QURE

Exane Derivatives's QURE Position: Q2 2022 in Review

Exane Derivatives held its uniQure (QURE) position steady in Q2 2022 at 8 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #698.

Exane Derivatives first reported a position in QURE in Q4 2018 and has held it in 8 quarters since. The position peaked at $151K in Q3 2021. 168 funds tracked by Wall St. Rank hold QURE as of Q2 2022.

  • Exane Derivatives held 8 shares of uniQure worth $149 as of Q2 2022.
  • Exane Derivatives left its uniQure share count unchanged in Q2 2022.
  • uniQure made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #698 holding.
  • Exane Derivatives first reported a position in uniQure in Q4 2018 and has held it in 8 quarters since.
  • Exane Derivatives's uniQure position peaked at $151K in Q3 2021.
  • 168 funds tracked by Wall St. Rank held uniQure as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.